Skip to content

Drug interactions

Atogepant + Efavirenz

Severity: Moderate

Atogepant and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz is a moderate to strong CYP3A4 inducer and can lower atogepant exposure, which may reduce migraine prevention efficacy.

What this interaction means in plain words

Atogepant and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Atogepant belongs to Central Nervous System; Efavirenz belongs to Anti Virals.

Evidence level: Moderate

Why it happens

CYP3A4 induction by efavirenz increases atogepant metabolism.

What to do

Use an atogepant dose of 30 mg or 60 mg once daily during efavirenz co-therapy, as labeling advises for CYP3A4 inducers. Monitor migraine control.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Efavirenz?

MediHelp rates the interaction as moderate. Atogepant and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz is a moderate to strong CYP3A4 inducer and can lower atogepant exposure, which may reduce migraine prevention efficacy.

How serious is the interaction between Atogepant and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use an atogepant dose of 30 mg or 60 mg once daily during efavirenz co-therapy, as labeling advises for CYP3A4 inducers. Monitor migraine control.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in